2[2]Purdue PE, Lumb M J, Fox M, et al. Characterization and chromosomal mapping of a genomic clone encoding human alanine: glyoxylate aminotransferase [J]. Genomics,1991,10(1): 34-42.
3[3]Cochat P, Deloraine A, Rotily M, et al. Epidemiology of primary hyperoxaluria type 1 [J]. Nephrol Dial Transplant,1995,10(suppl 8): 3-7.
4[4]Cochat P, Deloraine A, Olive F, et al. Primary hyperoxaluria type 1: the therapeutic dilemma [J]. Adv Nephrol Necker Hosp, 1995,24: 227-242.
5[5]Marangella M, Vitale C, Petrarulo M, et al. Bony content of oxalate in patients with primary hyperoxaluria or oxalosis-unrelated renal failure[J]. Kidney Int, 1995,48(1):182-187.
6[6]Gaulier JM, Cochat P, Larder G, et al. Serum oxalate microassay using chemiluminescence detection [J]. Kidney Int, 1997,52(6): 1700-1703.
7[7]Kasidas GP. Plasma and urine measurements for monitoring of treatment in the primary hyperoxaluric patient [J].Nephrol Dial Transplant, 1995,10(suppl 8): 8-10.
8[8]Barratt TM, Kasidas GP, Murdoch I, et al. Urinary oxalate and glycolate excretion and plasma oxalate concentration[J]. Arch Dis Child, 1991,66(4):501-503.
9[9]Milliner DS, Eickholt JT, Bergstrahl E J, et al. Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria[J]. N Engl J Med,1994,331(23):1553-1558.
10[10]Hoppe B, Graf D, Offner G, et al. Oxalate elimination via hemodialysis or peritoneal dialysis in children with chronic renal failure[J]. Pediatr Nephrol, 1996,10(4):488-492.
